IceCure Medical (ICCM) Profit After Tax (2020 - 2026)

IceCure Medical (ICCM) has reported Profit After Tax for 7 consecutive years, with $4.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Profit After Tax rose 33.8% year-over-year to $4.5 million in Q2 2026; TTM through Jun 2026 was $16.9 million, a 8.34% increase from a year earlier, with the FY2025 full-year figure at $15.1 million, down 1.7% from the prior year.
• Profit After Tax was $4.5 million for Q2 2026 at IceCure Medical, up from $4.3 million in the prior quarter.
• Over five years, Profit After Tax peaked at $4.5 million in Q2 2022 and troughed at $3.0 million in Q4 2023.
• A 5-year average of $3.9 million and a median of $4.0 million in 2022 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax soared 224.36% in 2022 and decreased 24.22% in 2023, its largest moves.
• Over 5 years, Profit After Tax stood at $4.0 million in 2022, then declined by 24.22% to $3.0 million in 2023, then jumped by 49.55% to $4.5 million in 2024, then fell by 5.2% to $4.2 million in 2025, then advanced by 6.01% to $4.5 million in 2026.
• The last three Profit After Tax figures came in at $4.5 million (Q2 2026), $4.3 million (Q1 2026), and $4.2 million (Q4 2025), per Business Quant data.